Transient receptor potential ankyrin1 channel is endogenously expressed in T cells and is involved in immune functions

Biosci Rep. 2019 Sep 20;39(9):BSR20191437. doi: 10.1042/BSR20191437. Print 2019 Sep 30.

Abstract

Transient receptor potential channel subfamily A member 1 (TRPA1) is a non-selective cationic channel, identified initially as a cold sensory receptor. TRPA1 responds to diverse exogenous and endogenous stimuli associated with pain and inflammation. However, the information on the role of TRPA1 toward T-cell responses remains scanty. In silico data suggest that TRPA1 can play an important role in the T-cell activation process. In this work, we explored the endogenous expression of TRPA1 and its function in T cells. By reverse transcription polymerase chain reaction (RT-PCR), confocal microscopy and flow cytometry, we demonstrated that TRPA1 is endogenously expressed in primary murine splenic T cells as well as in primary human T cells. TRPA1 is primarily located at the cell surface. TRPA1-specific activator namely allyl isothiocyanate (AITC) increases intracellular calcium ion (Ca2+) levels while two different inhibitors namely A-967079 as well as HC-030031 reduce intracellular Ca2+ levels in T cells; TRPA1 inhibition also reduces TCR-mediated calcium influx. TRPA1 expression was found to be increased during αCD3/αCD28 (TCR) or Concanavalin A (ConA)-driven stimulation in T cells. TRPA1-specific inhibitor treatment prevented induction of cluster of differentiation 25 (CD25), cluster of differentiation 69 (CD69) in ConA/TCR stimulated T cells and secretion of cytokines like tumor necrosis factor (TNF), interferon γ (IFN-γ), and interleukin 2 (IL-2) suggesting that endogenous activity of TRPA1 may be involved in T-cell activation. Collectively these results may have implication in T cell-mediated responses and indicate possible role of TRPA1 in immunological disorders.

Keywords: Ca2+-influx; Immunity; T-cells; TRPA1; immune regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetanilides / pharmacology
  • Animals
  • Antigens, CD / immunology
  • Antigens, Differentiation, T-Lymphocyte / immunology
  • CD28 Antigens / immunology
  • CD3 Complex / immunology
  • Calcium / immunology
  • Calcium / metabolism
  • Computer Simulation
  • Concanavalin A / pharmacology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / immunology
  • Humans
  • Immunity, Cellular / genetics*
  • Immunity, Cellular / immunology
  • Interferon-gamma / immunology
  • Interleukin-2 / immunology
  • Interleukin-2 Receptor alpha Subunit / immunology
  • Isothiocyanates / pharmacology
  • Lectins, C-Type / immunology
  • Mice
  • Oximes / pharmacology
  • Primary Cell Culture
  • Purines / pharmacology
  • T-Lymphocytes / immunology*
  • TRPA1 Cation Channel / agonists
  • TRPA1 Cation Channel / antagonists & inhibitors
  • TRPA1 Cation Channel / genetics*
  • TRPA1 Cation Channel / immunology
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / immunology*
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • 2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(4-isopropylphenyl)acetamide
  • A 967079
  • Acetanilides
  • Antigens, CD
  • Antigens, Differentiation, T-Lymphocyte
  • CD28 Antigens
  • CD3 Complex
  • CD69 antigen
  • IFNG protein, human
  • Interleukin-2
  • Interleukin-2 Receptor alpha Subunit
  • Isothiocyanates
  • Lectins, C-Type
  • Oximes
  • Purines
  • TRPA1 Cation Channel
  • Trpa1 protein, mouse
  • Tumor Necrosis Factor Receptor Superfamily, Member 7
  • Tumor Necrosis Factor-alpha
  • Concanavalin A
  • Interferon-gamma
  • allyl isothiocyanate
  • Calcium